Join us at Booth #3433 to meet our team of lab experts and learn about our cutting-edge research in immuno-oncology drug development.

Our posters will showcase our work in developing cost-effective in vitro assays for immunogenicity screening, oxygen gradient microplates for phenotypic and functional characterization of macrophages, and TPIPE, a pipeline for identifying therapeutic cancer vaccine candidates.

We are committed to providing the right solutions for our customers by combining scientific expertise, specialized lab services, and advanced technologies. Let us help you achieve your goals efficiently and effectively.

You're invited to join us at the upcoming sessions on April 28th, showcasing three poster presentations by our lead scientists Christoph Schifflers, PhD, and Dr. Martijn Vlaming.

• Apr. 28, 2025, 9:00 AM - 12:00 PM 
  Ready-to-use oxygen gradient microplates for customized in vitro assays for the phenotypic and functional characterization of primary macrophages in immuno-oncology drug development
• Apr. 28, 2025, 9:00 AM - 12:00 PM 
  Development and optimization of cost-effective non-human primate in vitro assays for immunogenicity screening and functional evaluation of immuno-oncology drug candidates
• Apr. 28, 2025, 2:00 PM - 5:00 PM 
  TPIPE, a pipeline for the identification and functional assessment of therapeutic cancer vaccine candidates 
  
  

AACR Booth Collateral:

• Tumor Mutational Burden (TMB) Assay for Response to Immunotherapy  
• Microsatellite Instability Assay for Response to Immunotherapy  
• Innovation Laboratory (TSAIL/Genomics)
• Biotech Laboratory Solutions
• Central Labs
• Cell & Gene Therapy
• Corporate Brochure
• Single Cell RNA Sequencing